SPOTLIGHT: Kiadis gets positive Phase II results

Kiadis Pharma has announced positive results from a Phase II clinical trial evaluating Reviroc, which is used to eliminate cancer cells from an autologous graft in bone marrow transplantations for end-stage blood cancer patients. Release